Background Bone mineral density (BMD) is known to fluctuate with age, hormonal profile, or presence of comorbidities. Bone evaluation in HIV positive patients is mandatory, particularly in those who acquired infection early in childhood, when bone turnover is high. Data in field literature on the prevalence of osteopenia or osteoporosis in HIV infection are heterogeneous, and the studies performed are not comparable due to essential differences in the followed cohorts. To address this issue we have performed a literature review to gather data on BMD in HIV infection. Review methodology We searched PubMed for the following key terms: "HIV”, "osteopenia”, "osteoporosis”, "bone”, "BMD”. All identified studies relevant to this topic were included in the analysis. The following parameters were collected for each study: number of participants, country of participants, prevalence of lumbar and femoral osteopenia and osteoporosis, mean or median age, mean or median duration of HIV infection, nadir CD4 cell count, and any particular comments. Literature review and Conclusion Data reported in field literature regarding osteopenia and osteoporosis are extremely heterogeneous in nature. This is in part due to the profound differences in the cohorts of patients, i.e., recently diagnosed patients vs. long-term survivors, but also due to the different definitions used for describing low BMD. Caution is warranted when comparing results of different studies.